|
1
|
Reproduced with permission from the NCCN
Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for
Head and Neck Cancers V.1.2020. © 2020 National Comprehensive
Cancer Network, Inc. All rights reserved. The NCCN Guidelines® and
illustrations herein may not be reproduced in any form for any
purpose without the express written permission of NCCN. To view the
most recent and complete version of the NCCN Guidelines, go online
to https://www.nccn.org. The NCCN
Guidelines are a work in progress that may be refined as often as
new significant data becomes available. NCCN makes no warranties of
any kind whatsoever regarding their content, use or application and
disclaims any responsibility for their application or use in any
way.
|
|
2
|
Porceddu SV and Weber RS: Management of
the neck following definitive radiotherapy with or without
chemoradiotherapy in head and neck squamous cell carcinoma. Post
TW, ed. UpToDate. Waltham, MA, 2018.
|
|
3
|
Mehanna H, Wong WL, McConkey CC, Rahman
JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H,
Robinson M, et al: PET-CT surveillance versus neck dissection in
advanced head and neck cancer. N Engl J Med. 374:1444–1454.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Garden AS, Gunn GB, Hessel A, Beadle BM,
Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, et
al: Management of the lymph node-positive neck in the patient with
human papillomavirus-associated oropharyngeal cancer. Cancer.
120:3082–3088. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Goenka A, Morris LG, Rao SS, Wolden SL,
Wong RJ, Kraus DH, Ohri N, Setton J, Lok BH, Riaz N, et al:
Long-term regional control in the observed neck following
definitive chemoradiation for node-positive oropharyngeal squamous
cell cancer. Int J Cancer. 133:1214–1221. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Koshkareva Y, Branstetter BF, Gaughan JP
and Ferris RL: Predictive accuracy of first post-treatment PET/CT
in HPV-related oropharyngeal squamous cell carcinoma. Laryngoscope.
124:1843–1847. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chan JY, Sanguineti G, Richmon JD, Marur
S, Gourin CG, Koch W, Chung CH, Quon H, Bishop JA, Aygun N and
Agrawal N: Retrospective review of positron emission tomography
with contrast-enhanced computed tomography in the posttreatment
setting in human papillomavirus-associated oropharyngeal carcinoma.
Arch Otolaryngol Head Neck Surg. 138:1040–1046. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vainshtein JM, Spector ME, Stenmark MH,
Bradford CR, Wolf GT, Worden FP, Chepeha DB, McHugh JB, Carey T,
Wong KK and Eisbruch A: Reliability of post-chemoradiotherapy
F-18-FDG PET/CT for prediction of locoregional failure in human
papillomavirus-associated oropharyngeal cancer. Oral Oncol.
50:234–239. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang K, Wong TZ, Amdur RJ, Mendenhall WM,
Sheets NC, Green R, Thorp BD, Patel SN, Hackman TG, Zanation AM, et
al: Pitfalls of post-treatment PET after de-intensified
chemoradiotherapy for HPV-associated oropharynx cancer: Secondary
analysis of a phase 2 trial. Oral Oncol. 78:108–113.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Helsen N, Van den Wyngaert T, Carp L and
Stroobants S: FDG-PET/CT for treatment response assessment in head
and neck squamous cell carcinoma: A systematic review and
meta-analysis of diagnostic performance. Eur J Nucl Med Mol
Imaging. 45:1063–1071. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taghipour M, Marcus C, Califano J, Fakhry
C and Subramaniam RM: The value of follow-up FDG-PET/CT in the
management and prognosis of patients with HPV-positive
oropharyngeal squamous cell carcinoma. J Med Imaging Radiat Oncol.
59:681–686. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shonka DC Jr, Shoushtari AN, Thomas CY,
Moskaluk C, Read PW, Reibel JF, Levine PA and Jameson MJ:
Predicting residual neck disease in patients with oropharyngeal
squamous cell carcinoma treated with radiation therapy: Utility of
p16 status. Arch Otolaryngol Head Neck Surg. 135:1126–1132.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Corpman DW, Masroor F, Carpenter DM, Nayak
S, Gurushanthaiah D and Wang KH: Posttreatment surveillance PET/CT
for HPV-associated oropharyngeal cancer. Head Neck. 41:456–462.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Huang SH, O'Sullivan B, Xu W, Zhao H, Chen
DD, Ringash J, Hope A, Razak A, Gilbert R, Irish J, et al: Temporal
nodal regression and regional control after primary radiation
therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Int J Radiat Oncol Biol Phys. 87:1078–1085. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Van der Putten L, Van den Broek GB, De
Bree R, van den Brekel MW, Balm AJ, Hoebers FJ, Doornaert P,
Leemans CR and Rasch CR: Effectiveness of salvage selective and
modified radical neck dissection for regional pathologic
lymphadenopathy after chemoradiation. Head Neck. 31:593–603.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fleischman GM, Thorp BD, Difurio M and
Hackman TG: Accuracy of ultrasonography-guided fine-needle
aspiration in detecting persistent nodal disease after
chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 142:377–382.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kao SS and Ooi EH: Survival outcomes
following salvage surgery for oropharyngeal squamous cell
carcinoma: Systematic review. J Laryngol Otol. 132:299–313.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu HY, Milne R, Lock G, Panizza BJ,
Bernard A, Foote M, McGrath M, Brown E, Gandhi M and Porceddu SV:
Utility of a repeat PET/CT scan in HPV-associated oropharyngeal
cancer following incomplete nodal response from
(chemo)radiotherapy. Oral Oncol. 88:153–159. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bird T, Barrington S, Thavaraj S, Jeannon
JP, Lyons A, Oakley R, Simo R, Lei M and Guerrero Urbano T:
(18)F-FDG PET/CT to assess response and guide risk-stratified
follow-up after chemoradiotherapy for oropharyngeal squamous cell
carcinoma. Eur J Nucl Med Mol Imaging. 43:1239–1247.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Goguen LA, Chapuy CI, Li Y, Zhao SD and
Annino DJ: Neck dissection after chemoradiotherapy: Timing and
complications. Arch Otolaryngol Head Neck Surg. 136:1071–1077.
2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Subramaniam RM, Alluri KC, Tahari AK,
Aygun N and Quon H: PET/CT imaging and human papilloma
virus-positive oropharyngeal squamous cell cancer: Evolving
clinical imaging paradigm. J Nucl Med. 55:431–438. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pellini R, Manciocco V, Turri-zanoni M,
Vidiri A, Sanguineti G, Marucci L, Sciuto R, Covello R, Sperduti I,
Kayal R, et al: Planned neck dissection after chemoradiotherapy in
advanced oropharyngeal squamous cell cancer: The role of US, MRI
and FDG-PET/TC scans to assess residual neck disease. J
Craniomaxillofac Surg. 42:1834–1839. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yu Y, Mabray M, Silveira W, Shen PY, Ryan
WR, Uzelac A and Yom SS: Earlier and more specific detection of
persistent neck disease with diffusion-weighted MRI versus
subsequent PET/CT after definitive chemoradiation for oropharyngeal
squamous cell carcinoma. Head Neck. 39:432–438. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Greuter MJ, Schouten CS, Castelijns JA, de
Graaf P, Comans EF, Hoekstra OS, de Bree R and Coupé VM:
Cost-effectiveness of response evaluation after chemoradiation in
patients with advanced oropharyngeal cancer using
18F-FDG-PET-CT and/or diffusion-weighted MRI. BMC
Cancer. 17(256)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gupta GP, Kumar S, Marron D, Amdur RJ,
Hayes DN, Weiss J, Grilley-Olson J, Zanation A, Hackman T, Zevallos
JP, et al: Circulating tumor HPV16 DNA as a biomarker of tumor
genomics and disease control in HPV-associated oropharyngeal
squamous cell carcinoma. Int J Radiat Oncol Biol Phys.
100:1310–1311. 2018.
|
|
26
|
Ahn SM, Chan JY, Zhang Z, Wang H, Khan Z,
Bishop JA, Westra W, Koch WM and Califano JA: Saliva and plasma
quantitative polymerase chain reaction-based detection and
surveillance of human papillomavirus-related head and neck cancer.
JAMA Otolaryngol Head Neck Surg. 140:846–854. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dahlstrom KR, Li G, Hussey CS, Vo JT, Wei
Q, Zhao C and Sturgis EM: Circulating human papillomavirus DNA as a
marker for disease extent and recurrence among patients with
oropharyngeal cancer. Cancer. 121:3455–3464. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jensen KK, Grønhøj C, Jensen DH and Von
buchwald C: Circulating human papillomavirus DNA as a surveillance
tool in head and neck squamous cell carcinoma: A systematic review
and meta-analysis. Clin Otolaryngol. 43:1242–1249. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lee JY, Garcia-Murillas I, Cutts RJ, De
Castro DG, Grove L, Hurley T, Wang F, Nutting C, Newbold K,
Harrington K, et al: Predicting response to radical
(chemo)radiotherapy with circulating HPV DNA in locally advanced
head and neck squamous carcinoma. Br J Cancer. 117:876–883.
2017.PubMed/NCBI View Article : Google Scholar
|
